Valerion Therapeutics' Series A Round

Valerion Therapeutics raised a round of funding on March 05, 2012. Investors include KLP Enterprises.

Valerion Therapeutics, formelry 4s3 Bioscience, is a biotechnology company focused on developing genetic disease therapies for orphan neuromuscular disorders. The company's platform is an antibody-bas…

Articles about Valerion Therapeutics' Series A Round: